title: Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient.
authors.forename: Leonidas
authors.initials: L
authors.lastname: Benetatos
authors.forename: Eleftheria
authors.initials: E
authors.lastname: Hatzimichael
authors.forename: Amalia
authors.initials: A
authors.lastname: Vassou
authors.forename: Konstantinos L
authors.initials: KL
authors.lastname: Bourantas
mesh_terms: D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003453:Cryptococcosis / Q000150:complications* / Q000000981:diagnostic imaging; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy*; D008172:Lung Diseases, Fungal / Q000150:complications* / Q000000981:diagnostic imaging; D008297:Male; D009894:Opportunistic Infections / Q000000981:diagnostic imaging; D013902:Radiography, Thoracic; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000935:Antifungal Agents; D000970:Antineoplastic Agents; D015725:Fluconazole; D014740:Vidarabine; C024352:fludarabine